Where does Alain Huriez work?

Alain Huriez is Chairman and Managing Partner at AdBio partners.

What does Alain Huriez invest in?

Alain Huriez invests in Biotech.

What check size does Alain Huriez write?

Alain Huriez typically writes checks of $25K – $5M.

Where did Alain Huriez go to school?

Alain Huriez studied at University of Paris I: Panthéon-Sorbonne (Master in Pharmaco Economics); Université de Picardie Jules Verne (Amiens) (Doctor of Medicine - MD, Thesis on Myotonic Dystrophy (molecular genetic and clinical study)); Université de Picardie Jules Verne (Amiens) (Master's degree, Institut d'Administration des Entreprises).

Alain Huriez

Investor

Chairman and Managing Partner at AdBio partners · Venture Partner at Advent Life Sciences

Paris, France

Writes $25K – $5M checks · typically $1M

About

Alain Huriez has 32 years of experience in life sciences, beginning his career in the mid-1980s in emergency medicine and general practice in France. He later spent 12 years in biotech drug development and regulatory strategy as VP of Quintiles (IQVIA) Biotech in Europe, then became an entrepreneur, serving as Associate Partner at Truffle Capital and CEO of Neovacs and TcLand, and founding five French biotechnology companies. He joined Advent Life Sciences in 2012 and founded AdBio Partners (formerly Advent France Biotechnology) in 2016, managing early-stage life sciences seed funds.

Contact· self-published, not guessed

a•••@adventls.comreveal

Invests in

Biotech

Experience

AdBio partnersChairman & Managing Partnercurrent2015 — presentGreater Paris Metropolitan Region
Advent Life SciencesVenture Partnercurrent2022 — present
Advent Life SciencesPartner2014 — 2021London Area, United Kingdom
Advent Life SciencesVenture Partner2012 — 2014London Area, United Kingdom
FONDATION ALBERT GLEIZESPresidentcurrent2006 — presentParis, Île-de-France, France
OrphalanChairman of the Board2015 — 2022Greater Paris Metropolitan Region
EPEMEDHonorary Chairman2016 — 2021Luxembourg
EPEMEDFounder and Chairman2009 — 2015Luxembourg
TcLand (split in TcLand Expression & Effimune-> Ose-Immunotherapeutics)Chief Executive Officer2006 — 2012
NEOVACS SAChief Executive Officer2003 — 2006Greater Paris Metropolitan Region
Truffle CapitalAssociate Partner2002 — 2003
IQVIAVice President Europe Biotechnology1995 — 2002
PSI CRO AGInternational Project Manager - Project Director1991 — 1995
CHU Amiens-PicardiePhysician- Head of Emergency Room1987 — 1991

Colleagues at AdBio partners

Clément Bertholet

Managing Partner at AdBio partners

Geoffroy de Ribains

Investor at AdBio partners

Network4

Alan Walts

Venture Partner at Advent Life Sciences

Dominic Schmidt

General Partner at Advent Life Sciences

Don Drakeman

Distinguished Research Professor, biotech entrepreneur, and venture partner

Kaasim Mahmood

General Partner at Advent Life Sciences

Investors connected to Alain in public investor directories — a warm-intro map.

Frequently asked questions

Who is Alain Huriez?: Alain Huriez has 32 years of experience in life sciences, beginning his career in the mid-1980s in emergency medicine and general practice in France. He later spent 12 years in biotech drug development and regulatory strategy as VP of Quintiles (IQVIA) Biotech in Europe, then became an entrepreneur, serving as Associate Partner at Truffle Capital and CEO of Neovacs and TcLand, and founding five French biotechnology companies. He joined Advent Life Sciences in 2012 and founded AdBio Partners (formerly Advent France Biotechnology) in 2016, managing early-stage life sciences seed funds.
Where does Alain Huriez work?: Alain Huriez is Chairman and Managing Partner at AdBio partners.
What does Alain Huriez invest in?: Alain Huriez invests in Biotech.
What check size does Alain Huriez write?: Alain Huriez typically writes checks of $25K – $5M.
Where did Alain Huriez go to school?: Alain Huriez studied at University of Paris I: Panthéon-Sorbonne (Master in Pharmaco Economics); Université de Picardie Jules Verne (Amiens) (Doctor of Medicine - MD, Thesis on Myotonic Dystrophy (molecular genetic and clinical study)); Université de Picardie Jules Verne (Amiens) (Master's degree, Institut d'Administration des Entreprises).

Same school

Also attended University of Paris I: Panthéon-Sorbonne171

Thomas WolfCo-founder & Chief Science Officer of Hugging Face Julie YangVice President at Investcorp Claire TanguyInvestor at Daphni Pierre-Eric LeiboviciInvestor at Daphni Sauvanne Saint-LégerInvestor at Daphni Sophie de ChampsInvestor at Daphni

+ 165 more

Also attended Université de Picardie Jules Verne (Amiens)7

Pauline BowmanCompliance Officer at Lauxera Capital Partners Paul BramleyDirector & Consultant at Claret Capital Partners Clément WardzalaDirecteur de publication at Cryptoast Akcan IstifHead of Innovation & Labs at Scientifica Venture Capital Maxime DurandInvestor at Agape Patrimoine Hanane BaoualiFamily Data Keeper at Ivesta Family Office

+ 1 more

Shared employers

Also worked at Truffle Capital13

Mark BivensVenture Partner at Great Wave Ventures Clarisse LamInvestment Manager at TX Ventures Bernard-Louis RoquesCEO and Co-Founder at Truffle Capital Diane YakovlevInvestment Manager at Supernova Invest Mithi ThayaPharma Advisor at Exceptional Ventures Edouard BoissonInvestment Associate at Opera Tech Ventures

+ 7 more

Also worked at IQVIA50

Scott DonohueSenior Director, Market Access at Deerfield Management Company Dana Marohn SpiliotisPartner at Operator Collective Roel DekkersInvestment manager at Noaber Maulik MehtaManaging Partner at Excelerate Health Ventures Martin GouldstoneDigital Pharma Advisor at Excelerate Health Ventures Jeanne HechtDigital Pharma Advisor at Excelerate Health Ventures

+ 44 more